Chemed Corp (CHE)
561.65
+2.00
(+0.36%)
USD |
NYSE |
May 03, 16:00
561.98
+0.34
(+0.06%)
After-Hours: 20:00
Chemed SG&A Expense (Quarterly): 115.87M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 115.87M |
December 31, 2023 | 100.44M |
September 30, 2023 | 99.60M |
June 30, 2023 | 94.99M |
March 31, 2023 | 100.10M |
December 31, 2022 | 96.93M |
September 30, 2022 | 83.99M |
June 30, 2022 | 87.85M |
March 31, 2022 | 89.95M |
December 31, 2021 | 92.07M |
September 30, 2021 | 89.22M |
June 30, 2021 | 93.84M |
March 31, 2021 | 91.60M |
December 31, 2020 | 86.80M |
September 30, 2020 | 88.32M |
June 30, 2020 | 84.51M |
March 31, 2020 | 70.58M |
December 31, 2019 | 83.29M |
September 30, 2019 | 76.84M |
June 30, 2019 | 71.56M |
March 31, 2019 | 74.03M |
December 31, 2018 | 66.74M |
September 30, 2018 | 67.18M |
June 30, 2018 | 68.30M |
March 31, 2018 | 69.00M |
Date | Value |
---|---|
December 31, 2017 | 71.62M |
September 30, 2017 | 66.92M |
June 30, 2017 | 68.65M |
March 31, 2017 | 69.46M |
December 31, 2016 | 62.53M |
September 30, 2016 | 59.37M |
June 30, 2016 | 67.12M |
March 31, 2016 | 59.04M |
December 31, 2015 | 64.55M |
September 30, 2015 | 55.79M |
June 30, 2015 | 58.44M |
March 31, 2015 | 59.04M |
December 31, 2014 | 59.70M |
September 30, 2014 | 53.57M |
June 30, 2014 | 53.65M |
March 31, 2014 | 55.67M |
December 31, 2013 | 58.03M |
September 30, 2013 | 48.87M |
June 30, 2013 | 53.11M |
March 31, 2013 | 55.56M |
December 31, 2012 | 52.76M |
September 30, 2012 | 52.96M |
June 30, 2012 | 49.77M |
March 31, 2012 | 53.17M |
December 31, 2011 | 48.56M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
70.58M
Minimum
Mar 2020
115.87M
Maximum
Mar 2024
89.92M
Average
89.59M
Median
SG&A Expense (Quarterly) Benchmarks
Amedisys Inc | 193.32M |
Addus HomeCare Corp | 60.77M |
Regional Health Properties Inc | 0.786M |
OptimizeRx Corp | 12.89M |
Option Care Health Inc | 154.74M |